{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T13:02:18Z","timestamp":1740142938881,"version":"3.37.3"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"7-8","license":[{"start":{"date-parts":[[2019,10,24]],"date-time":"2019-10-24T00:00:00Z","timestamp":1571875200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,10,24]],"date-time":"2019-10-24T00:00:00Z","timestamp":1571875200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100005788","name":"Medical University of Vienna","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100005788","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Wien Klin Wochenschr"],"published-print":{"date-parts":[[2020,4]]},"abstract":"<jats:title>Summary<\/jats:title>\n              <jats:p>Current Advisory Committee on Immunization Practices (ACIP) guidelines recommend immunization of all human immunodeficiency virus (HIV)-infected patients against meningitis serotype ACWY due to recent outbreaks of meningitis\u00a0C in homosexual men in the USA. Implementation of this recommendation in other countries, such as Austria is hindered by the scarce knowledge on the vaccine coverage. In this study the serostatus for meningococcus serogroup C was analyzed  in 390 HIV-infected individuals residing in Austria. These individuals were representative for the Austrian HIV cohort regarding sex, age, transmission risk and HIV progression markers. Overall, 73% were on suppressive antiretroviral therapy, the mean CD4 cell count was 599\u00a0cells\/\u03bcl and immunoglobulin G (IgG) seropositivity was 18% for meningococcus serogroup\u00a0C. Migrants and patients who had acquired an infection via heterosexual intercourse had a\u00a0higher chance for meningococcus serogroup\u00a0C seropositivity. Importantly due to the well-preserved immune status of nearly all participants vaccination would be feasible in the majority of the seronegative patients. It is assumed that this measure would largely reduce the number of patients at risk for this vaccine-preventable disease.<\/jats:p>","DOI":"10.1007\/s00508-019-01561-4","type":"journal-article","created":{"date-parts":[[2019,10,25]],"date-time":"2019-10-25T01:21:25Z","timestamp":1571966485000},"page":"171-175","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Low seroprotection rate for meningococcus serogroup\u00a0C in the adult HIV-1-infected population in Austria"],"prefix":"10.1007","volume":"132","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0665-5414","authenticated-orcid":false,"given":"Katharina","family":"Grabmeier-Pfistershammer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kay","family":"Holleis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sandra","family":"Rosskopf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Steinberger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Veronique","family":"Touzeau-Roemer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wolfgang","family":"Poeppl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Armin","family":"Rieger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,10,24]]},"reference":[{"issue":"3","key":"1561_CR1","first-page":"131","volume":"18","author":"M Wateba","year":"2008","unstructured":"Wateba\u00a0M, Diop\u00a0S, Nichols\u00a0S, et\u00a0al. Tetanus and HIV: a\u00a0fortuitous association. Sante. 2008;18(3):131\u20134.","journal-title":"Sante"},{"issue":"50","key":"1561_CR2","doi-asserted-by":"publisher","first-page":"7059","DOI":"10.1016\/j.vaccine.2009.09.063","volume":"27","author":"PF Belaunzar\u00e1n-Zamudio","year":"2009","unstructured":"Belaunzar\u00e1n-Zamudio\u00a0PF, Garc\u00eda-Le\u00f3n\u00a0ML, Wong-Chew\u00a0RM, et al. Early loss of measles antibodies after MMR vaccine among HIV-infected adults receiving HAART. Vaccine. 2009;27(50):7059\u201364.","journal-title":"Vaccine"},{"issue":"7","key":"1561_CR3","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.1086\/319591","volume":"32","author":"S Berkelhamer","year":"2001","unstructured":"Berkelhamer\u00a0S, Borock\u00a0E, Elsen\u00a0C, Englund\u00a0J, Johnson\u00a0D. Effect of highly active antiretroviral therapy on the serological response to additional measles vaccinations in human immunodeficiency virus-infected children. Clin Infect Dis. 2001;32(7):1090\u20134.","journal-title":"Clin Infect. Dis"},{"key":"1561_CR4","unstructured":"EACS Guidelines 2017\u2014European AIDS Clinical Society, \nwww.eacsociety.org\/files\/guidelines_9.0-english.pdf"},{"issue":"43","key":"1561_CR5","first-page":"1189","volume":"65","author":"ACIP","year":"2016","unstructured":"ACIP. Recommendations for use of meningococcal conjugate vaccines in HIV-infected persons\u2014advisory committee on immunization practices. MMWR Recomm Rep. 2016;65(43):1189\u201394.","journal-title":"MMWR Recomm Rep"},{"issue":"9","key":"1561_CR6","doi-asserted-by":"publisher","first-page":"4411","DOI":"10.1128\/JCM.41.9.4411-4414.2003","volume":"41","author":"RS Tsang","year":"2003","unstructured":"Tsang\u00a0RS, Kiefer\u00a0L, Law\u00a0DK, et al. Outbreak of serogroup C meninigococcal disease caused by variant of N. meningitis serotype 2a ET-15 in a\u00a0community of men who have sex with men. J\u00a0Clin Microbiol. 2003;41(9):4411\u20134.","journal-title":"J Clin Microbiol"},{"key":"1561_CR7","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-159-4-201308200-00674","author":"MS Simon","year":"2013","unstructured":"Simon\u00a0MS, Weiss\u00a0D, Gulick\u00a0RM. Invasive meningococcal diseas in men who have sex with men. Ann Intern Med. 2013; \nhttps:\/\/doi.org\/10.7326\/0003-4819-159-4-201308200-00674\n\n.","journal-title":"Ann Intern Med"},{"issue":"51-52","key":"1561_CR8","first-page":"1048","volume":"61","author":"Centers for Disease Control and Prevention (CDC)","year":"2013","unstructured":"Centers for Disease Control and Prevention (CDC). Notes from the field: serogroup C invasive meningococcal disease among men who have sex with men\u2014New York City, 2010-2012. MMWR Morb Mortal Wkly Rep. 2013;61(51-52):1048\u20131044.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"8","key":"1561_CR9","doi-asserted-by":"publisher","first-page":"e0160126","DOI":"10.1371\/journal.pone.0160126","volume":"11","author":"W Hellebrand","year":"2016","unstructured":"Hellebrand\u00a0W, Claus\u00a0H, Schink\u00a0S. Risk of invasive meningococcal disease in men who have sex with men: lessons learned from an outbreak in Germany. 2012-2013. Plos One. 2016;11(8):e160126.","journal-title":"Plos One"},{"key":"1561_CR10","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1016\/j.jinf.2013.10.008","volume":"68","author":"MW Bijlsma","year":"2014","unstructured":"Bijlsma\u00a0MW, van den Kerkhof\u00a0H, van de Beek\u00a0D, et\u00a0al. No evidence of clusters of serogroup C meningococcal disease in the Dutch MSM community. J\u00a0Infect. 2014;68:296\u2013302.","journal-title":"J Infect"},{"key":"1561_CR11","volume-title":"Impfplan \u00d6sterreich 2019","author":"Bundesministerium f\u00fcr Arbeit, Soziales, Gesundheit und Konsumentenschutz","year":"2019","unstructured":"Bundesministerium f\u00fcr Arbeit, Soziales, Gesundheit und Konsumentenschutz. Impfplan \u00d6sterreich 2019. 2019. \nhttps:\/\/www.sozialministerium.at\/cms\/site\/attachments\/5\/4\/7\/CH4062\/CMS1546865142466\/190211_impfplan_oesterreich_2019_web.pdf\n\n."},{"key":"1561_CR12","doi-asserted-by":"publisher","first-page":"3929","DOI":"10.1016\/j.vaccine.2015.06.056","volume":"33","author":"K Grabmeier-Pfistershammer","year":"2015","unstructured":"Grabmeier-Pfistershammer\u00a0K, Herkner\u00a0H, Touzeau-Roemer\u00a0V, et al. Low tetanus, diphtheria and cellular pertussis (Tdap) vaccination coverage among HIV infected individuals in Austria. Vaccine. 2015;33:3929\u201332.","journal-title":"Vaccine"},{"issue":"45","key":"1561_CR13","doi-asserted-by":"publisher","first-page":"6020","DOI":"10.1016\/j.vaccine.2014.07.114","volume":"32","author":"K Grabmeier-Pfistershammer","year":"2014","unstructured":"Grabmeier-Pfistershammer\u00a0K, Poeppl\u00a0W, Herkner\u00a0H, et al. High need for MMR vaccination in HIV infected adults in Austria. Vaccine. 2014;32(45):6020\u20133.","journal-title":"Vaccine"},{"issue":"8","key":"1561_CR14","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.1128\/CVI.05655-11","volume":"19","author":"DA Ishola","year":"2012","unstructured":"Ishola\u00a0DA, Borrow\u00a0R, Findlow\u00a0H, et\u00a0al. Prevalence of serum bacterial antibody to serogroup C neisseria meningitides in England decade after Vaccine introduction. Clin Vaccine Immunol. 2012;19(8):1126\u201330. \nhttps:\/\/doi.org\/10.1128\/CVI.05655-11\n\n.","journal-title":"Clin Vaccine Immunol"},{"issue":"8","key":"1561_CR15","doi-asserted-by":"publisher","first-page":"e12144","DOI":"10.1371\/journal.pone.0012144","volume":"5","author":"RM De Voer","year":"2010","unstructured":"De Voer\u00a0RM, Mollema\u00a0L, Schepp\u00a0RM, et\u00a0al. Immunity against neisseria meningitides Serogroup C in the Dutch population before and after introduction of the meningococcal C conjugate vaccine. PLoS ONE. 2010;5(8):e12144.","journal-title":"PLoS ONE"},{"issue":"Suppl 1","key":"1561_CR16","doi-asserted-by":"publisher","first-page":"S58","DOI":"10.1016\/S0264-410X(01)00299-7","volume":"20","author":"E Miller","year":"2001","unstructured":"Miller\u00a0E, Salisbury\u00a0D, Ramsay\u00a0M. Planning, registration, and implementation of an immunisation campaign against\u00a0meningococcalserogroup C disease in the\u00a0UK: a\u00a0success story. Vaccine. 2001;20(Suppl 1):S58\u2013S67.","journal-title":"Vaccine"},{"issue":"9","key":"1561_CR17","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.1093\/cid\/ciu601","volume":"59","author":"MW Bijlsma","year":"2014","unstructured":"Bijlsma\u00a0MW, Brouwer\u00a0MC, Spanjaard\u00a0L, van de Beek\u00a0D, van der Ende\u00a0A. A decade of herd protection after introduction of meningococcal serogroup C conjugate vaccination. Clin Infect Dis. 2014;59(9):1216\u201321. \nhttps:\/\/doi.org\/10.1093\/cid\/ciu601\n\n.","journal-title":"Clin Infect Dis"},{"issue":"9431","key":"1561_CR18","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1016\/S0140-6736(04)16725-1","volume":"364","author":"CL Trotter","year":"2004","unstructured":"Trotter\u00a0CL, Andrews\u00a0NJ, Kaczmarski\u00a0EB, Miller\u00a0E, Ramsay\u00a0ME. Effectiveness of\u00a0meningococcal\u00a0serogroup C conjugate vaccine 4 years after introduction. Lancet. 2004;364(9431):365\u20137.","journal-title":"Lancet"},{"issue":"2","key":"1561_CR19","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1097\/01.inf.0000151029.58752.27","volume":"24","author":"MD Snape","year":"2005","unstructured":"Snape\u00a0MD, Kelly\u00a0DF, Green\u00a0B, Moxon\u00a0ER, Borrow\u00a0R, Pollard\u00a0AJ. Lack of serum bactericidal activity in preschool children two years after a\u00a0single dose of serogroup C\u00a0meningococcal\u00a0polysaccharide-protein conjugate vaccine. Pediatr Infect Dis\u00a0J. 2005;24(2):128\u201331.","journal-title":"Pediatr Infect Dis J"},{"issue":"7659","key":"1561_CR20","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.1136\/bmj.39563.545255.AE","volume":"336","author":"MD Snape","year":"2008","unstructured":"Snape\u00a0MD, Kelly\u00a0DF, Lewis\u00a0S, et\u00a0al. Seroprotection against serogroup C\u00a0meningococcal\u00a0disease in adolescents in the United Kingdom: observational study. BMJ. 2008;336(7659):1487\u201391. \nhttps:\/\/doi.org\/10.1136\/bmj.39563.545255.AE\n\n.","journal-title":"BMJ"},{"volume-title":"34th Report of the Austrian HIV Cohort Study","year":"2018","key":"1561_CR21","unstructured":"Zangerle\u00a0R, editor. 34th Report of the Austrian HIV Cohort Study. Innsbruck: Austrian HIV Cohort, AHIVCOS; 2018."}],"container-title":["Wiener klinische Wochenschrift"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00508-019-01561-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00508-019-01561-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00508-019-01561-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,22]],"date-time":"2020-10-22T23:32:36Z","timestamp":1603409556000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00508-019-01561-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10,24]]},"references-count":21,"journal-issue":{"issue":"7-8","published-print":{"date-parts":[[2020,4]]}},"alternative-id":["1561"],"URL":"https:\/\/doi.org\/10.1007\/s00508-019-01561-4","relation":{},"ISSN":["0043-5325","1613-7671"],"issn-type":[{"type":"print","value":"0043-5325"},{"type":"electronic","value":"1613-7671"}],"subject":[],"published":{"date-parts":[[2019,10,24]]},"assertion":[{"value":"17 May 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 September 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 October 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"K.\u00a0Grabmeier-Pfistershammer, K.\u00a0Holleis, S.\u00a0Rosskopf, P.\u00a0Steinberger, V.\u00a0Touzeau-Roemer, W.\u00a0Poeppl, and A.\u00a0Rieger declare that they have no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}